We have marked a distinct and dynamic position in the market by providing Sunitinib Malate Capsules, which are demanded to treat gastrointestinal stromal tumors or esophagus in people with tumors. These capsules are demanded for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy. Apart from this, these Sunitinib Malate Capsules are processed using advance methodology in accordance with medical norms.